Projects

Selected Industry Projects

  • Antihypertensive agents: amlodipine, ramipril – Phase 3 reports

  • Anti-infectives: azithromycin, linezolid – Phase 3 reports, quality control

  • Antiplatelet agent: clopidogrel – Phase 1 reports

  • Antithrombotic: factor Xa inhibitor – Phase 1 reports

  • Breast cancer: fulvestrant – Informed consent document

  • Diabetes: troglitazone – Phase 3 reports

  • Esophageal cancer: nimotuzumab – Protocol

  • Global Innovate!! Implementation of progressive business ideas

  • Hormone replacement: norethindrone acetate/ethinyl estradiol – Phase 3 reports

  • Hypercholesterolemia: torcetrapib / atorvastatin – Phase 2 reports

  • Neuropathic pain: gabapentin, pregabalin – Phase 3 reports, safety narratives

  • Progressive familial intrahepatic cholestasis (PFIC): odevixibat – Phase 3 report, Modules 2.7.3, 2.7.4

  • Renal disease: mycophenolate sodium – Protocol

  • Selective estrogen receptor modulator (SERM): lasofoxifene – Phase 2/3 reports

  • Smoking cessation: varenicline – Phase 3 reports

  • Workshops: Clinical Study Reports, GCP, ICH and the Declaration of Helsinki, Informed Consent, Search Strategies, Statistics in Medicine.

Leave a Reply

Your email address will not be published.